Company / Book Value per Share
BeOne Medicines Ltd. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.144
FY2025
5-year range
$2.451 / $5.084
FY2021-FY2025
Trend
+28.3%
vs FY2024
Sector context
#131 of 209
Health Care
What the data says
At $3.144, BeOne Medicines Ltd.'s book value per share ranks #131 of 209 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $3.144.
Based on SEC 10-K filings.
$3.144 in FY2025 with a 5-year CAGR of -8.2%.
Improved from $2.608 to $3.144 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -1.4%
- 5-Year CAGR
- -8.2%
- 10-Year CAGR
- -
Sector benchmark
#131 of 209 in Health CareTop 63% of 209This company $3.144 Sector average $215.686
▼
-98.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.2%, indicating a declining trend.
- In FY2025, book value per share increased 28.3% year-over-year.
- Ranks #131 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.144 | +28.3% |
| FY2024 | $2.451 | -6.0% |
| FY2023 | $2.608 | -20.6% |
| FY2022 | $3.284 | -35.4% |
| FY2021 | $5.084 | +5.3% |
| FY2020 | $4.828 | +289.5% |
| FY2019 | $1.24 | -57.8% |
| FY2018 | $2.937 | +126.2% |
| FY2017 | $1.298 | -57.3% |
| FY2016 | $3.038 | +430.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026